Andre Godin Named Interim President, CEO Of Neptune, Acasti, NeuroBio

(RTTNews) - Neptune Technologies & Bioressources Inc. (NEPT), Acasti Pharma Inc. (ACST) and NeuroBioPharm Inc., collectively refered to as the Corporation, jointly announced the appointment of Andre Godin as interim President and Chief Executive Officer of Neptune, Acasti and NeuroBio with immediate effect.

Godin is currently Chief Financial Officer of Neptune. Since the recent resignation of the Corporation's former president and CEO, Godin has also been overseeing the management of the business with the support of a management and operations committee.

Godin has been with Neptune since 2003. He has more than 20 years of industry experience, including as former President of a dietary supplement company and as a Corporate Controller for a pharmaceutical company in over-the-counter products.